💼Upcoming NIH Meetings on Grant Applications for Small Businesses
The Department of Health and Human Services announces closed meetings of the Center for Scientific Review to evaluate grant applications in various fields. These panels will focus on small business initiatives related to clinical care, cancer treatments, immuno-oncology, and more. Meetings are set to occur virtually at the National Institutes of Health in Bethesda, MD.
Learn More🧪Notice of Meeting for National Advisory Neurological Disorders and Stroke Council
The Department of Health and Human Services announces a public meeting of the National Advisory Neurological Disorders and Stroke Council to discuss concept clearance initiatives and various business matters. Participants requiring assistance are encouraged to notify the contact in advance. The meeting will be accessible via NIH Videocast for public attendance.
Learn More🧠NIH Meeting on Grant Opportunities for Neurological Research
The National Advisory Neurological Disorders and Stroke Council is scheduled to hold a closed meeting to review and evaluate grant applications. This meeting underlines the importance of confidentiality regarding trade secrets and personal information within the realm of neurological research funding.
Learn More❌Notice of Cancellation for NIH Meeting on K99/R00 Applications
The Department of Health and Human Services announces the cancellation of a meeting regarding the review of K99/R00 applications originally scheduled for July 2025. This meeting has been shifted from the National Institute of General Medical Sciences to the Center for Scientific Review, highlighting an organizational change within the NIH that may affect future research funding processes.
Learn More📊NIH Grant Application Review Meetings Announcement and Details
The Department of Health and Human Services issued a notice regarding closed meetings by the NIH's Center for Scientific Review, focusing on the evaluation of grant applications. The meetings will take place virtually and aim to discuss sensitive information, including trade secrets and personal data, emphasizing confidentiality in the review process.
Learn More❌NIH Cancels July 2025 COBRE Meeting Announcement
The Department of Health and Human Services announces the cancellation of the National Institute of General Medical Sciences Special Emphasis Panel meeting originally scheduled for July 2025. This cancellation follows the transfer of responsibilities to the Center for Scientific Review, aimed at streamlining the review process of biomedical research excellence programs.
Learn More❌Notice of Cancellation
The Department of Health and Human Services announces the cancellation of the National Institute of General Medical Sciences Special Emphasis Panel meeting scheduled for July 2025, due to its transfer to the Center for Scientific Review. This decision affects stakeholders involved in the review of biomedical research excellence programs.
Learn More🏥Upcoming Meeting on Child Health Grants by NIH Advisory Council
A notice from the National Institutes of Health announces an upcoming meeting of the National Advisory Child Health and Human Development Council. This meeting will review grant applications and discuss the NICHD Director's report, providing insights into child health research and potential funding opportunities for related businesses.
Learn More❌Cancellation of NIH Meeting on Biomedical Research Review
The notice announces the cancellation of a meeting for the National Institute of General Medical Sciences' Special Emphasis Panel, initially scheduled for July 2025, which focuses on the review of the Centers of Biomedical Research Excellence. The meeting has been transferred to the Center for Scientific Review.
Learn More🏥Cancellation of NIH Biomedical Meeting Notice
The Department of Health and Human Services has announced the cancellation of the National Institute of General Medical Sciences Special Emphasis Panel meeting scheduled for July 2025. The meeting has been transferred to the Center for Scientific Review, reflecting changes in oversight for biomedical research evaluation processes.
Learn More